Condition: Movement Disorders in Children · Neuro Developmental Delay · Neurogenetic Disorders · Sponsor: University of Medicine and Pharmacy at Ho Chi Minh City
This observational patient registry aims to describe the clinical phenotypes and genetic findings of Vietnamese children with movement disorders of unknown etiology. Eligible participants are children with clinically confirmed movement disorders after evaluation by pediatric neurology specialists and after exclusion of clear acquired causes. The study will collect clinical data, neurological examination findings, available laboratory and imaging results, and video recordings of abnormal movements when consent is provided. Blood samples will be collected for whole-exome sequencing and related genetic analysis. Genetic variants will be classified according to accepted clinical genetics standards and compared with the patients' clinical phenotypes. The study is expected to improve understanding of the phenotypic and genotypic spectrum of pediatric movement disorders in Vietnam, support genetic counseling, and evaluate how genetic results may influence diagnosis, follow-up, prognosis, and treatment planning.
This description comes directly from the study's public registry record.
Bich Y L Nguyen, MD, MSc, PhD Candidate · +84 939077089 · nbylinh.ncs25@ump.edu.vn
Hieu L. T. Nguyen, Assoc Prof, MD, PhD · +84 908393616 · ngletrunghieu@ump.edu.vn
Always discuss trial participation with your own doctor first.
| Children's Hospital 1, Ho Chi Minh City | Ho Chi Minh City, Ho Chi Minh City, Vietnam | Recruiting |
| University Medical Center Ho Chi Minh City | Ho Chi Minh City, Ho Chi Minh City, Vietnam | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07695610